New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.

Mairs, RJZalutsky, MR2015-12-031995-070007-0920https://hdl.handle.net/10161/110473-IodobenzylguanidineAntineoplastic AgentsCombined Modality TherapyHumansIodine RadioisotopesIodobenzenesNeuroblastomaNew MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.Journal article